Ginger Gregory - 19 Jan 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Reporting relationship: EVP, Human Resources
Issuer ticker: BIIB
Reported as of: 19 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jan 2022, 15:48:41 UTC
Next SEC filing: 14 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Wendell Taylor, attorney in fact for Ginger Gregory

Key filing fact

Ginger Gregory filed Form 4 for BIOGEN INC. (BIIB) on 21 Jan 2022.

Key facts

This page summarizes Ginger Gregory's Form 4 filing for BIOGEN INC. (BIIB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jan 2022, 15:48.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIIB transaction

Common Stock

Award

Transaction value: $0
Shares: +1,941
Change %: +24%
Price: $0.000000
Shares after: 10,028
Date: 19 Jan 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022.

Footnote F2

Includes 71.5888 shares, 14,2341 shares, 10.4331 shares and .0001 share acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021, 6/30/2021, 9/30/2021 and 12/31/2021, respectively.